Sometimes you opt to revisit a therapist that you've not seen for years. The same can apply to AI, going back to AI to ...
Reported $4.15 billion (YoY growth of +90%) in preliminary* full-year 2025 global product net sales, inclusive of $1.29 billion in fourth quarter ...
Human Papillomavirus HPV infection causes almost all cases of cervical cancer Our expert explains what HPV is its causes ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor ...
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , and Royalty Pharma plc , today announced a ...
Chiropractor Evansville Shares Perspective on the Role and Structure of Modern Chiropractic Services
January 10, 2026 - PRESSADVANTAGE - Chiropractor Evansville has released an announcement outlining its approach to ...
How does spinal decompression work, and why is it considered a gentle option for disc-related pain? LOCUST , NC, UNITED ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...
Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva's anti-IL-15 candidate TEV-'408TEV-' ...
CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results